The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...

Explore trends before investing – request a sample report today! The Non-NGS Predictive Cancer Diagnostics Market is ...

The global liquid biopsy market, poised for significant growth, benefits from increased demand for non-invasive cancer ...

The North American Nucleic Acid Amplification Testing (NAAT) market will reach $7.64 billion by 2033, growing from $3.28 ...

The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...

Ultrasensitive Molecular Amplification Market is projected to reach US$ 31.2 Bn by 2035, driven by rising chronic disease ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.